Dr Robert Popovian discusses access to immunization services among adults in low-income communities and efforts to expand pharmacists’ authority to administer vaccines to increase vaccination rates for this vulnerable population.
In this interview, Paritosh Prasad, MD, provides insight into the recent outbreak of monkeypox.
Researchers evaluated the effect of adjuvant colchicine with standard therapy among patients with moderate and severe COVID-19 infection.
Graham M. Snyder, MD, MS, provides further insight into a study that evaluated the effects of an early return-to-work program that reduced the quarantine period for clinicians who remained asymptomatic after exposure to COVID-19.
Researchers conducted a study that compared voter turnout between physicians and the general population for US elections held between 2000 and 2020.
In this Q&A, Erica Johnson, MD, provides insight into the new oral antiviral medications that may soon be approved for the treatment of COVID-19.
Researchers sought to compare the risk for hospital and emergency department admission for the treatment of COVID-19 among patients infected with the Alpha variant vs those with the Delta variant.
